{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types", "item": "https://www.patentleaderboard.com/patent/7901677"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types

Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types

US Patent 7901677 · Granted Mar 8, 2011

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tandem diabody for CD16A-directed NK-cell engagement2025
Tandem diabody for CD16A-directed NK-cell engagement2025
Bispecific EGFR/CD16 antigen-binding protein2024
Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for t2023
Multivalent FV antibodies2023
Drug conjugates comprising antibodies against claudin 18.22023
Combination of an anti-CD16A antibody with a cytokine2022
Bispecific EGFR/CD16 antigen-binding protein2022
Tandem diabody for CD16A-directed NK-cell engagement2021
Tandem diabody for CD16A-directed NK-cell engagement2021
Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy2021
Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy2021